Bayer, Meda sue Apotex over nasal spray
12-10-2021
mihailgrey / iStockphoto.com
The US Court of Appeals for the Federal Circuit denied Merck Sharp & Dohme’s (MSD) request for a new trial to determine whether Amneal infringed a patent related to a nasal spray on Friday, February 9.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Merck Sharp & Dohme, Amneal, US Court of Appeals for the Federal Circuit, nasal spray, generics, ANDA, FDA
